TD ASSET MANAGEMENT INC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,677,000
-17.3%
95,435
-69.2%
0.00%0.0%
Q2 2021$2,028,000
-39.2%
310,255
-0.5%
0.00%
-50.0%
Q1 2021$3,338,000
-22.8%
311,679
+6.0%
0.00%
-20.0%
Q4 2020$4,325,000
+26.6%
294,159
+21.9%
0.01%0.0%
Q3 2020$3,415,000
+453.5%
241,367
+215.2%
0.01%
+400.0%
Q2 2020$617,00076,5750.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders